ALBENZA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Albenza, and what generic alternatives are available?
Albenza is a drug marketed by Impax Labs Inc and is included in one NDA.
The generic ingredient in ALBENZA is albendazole. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the albendazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Albenza
A generic version of ALBENZA was approved as albendazole by STRIDES PHARMA on December 7th, 2018.
Summary for ALBENZA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 157 |
| Clinical Trials: | 3 |
| Patent Applications: | 3,498 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ALBENZA |
| What excipients (inactive ingredients) are in ALBENZA? | ALBENZA excipients list |
| DailyMed Link: | ALBENZA at DailyMed |
Recent Clinical Trials for ALBENZA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Lihir Medical Centre | Phase 3 |
| Bill and Melinda Gates Foundation | Phase 3 |
| University of Washington | Phase 3 |
Pharmacology for ALBENZA
| Drug Class | Anthelmintic |
| Mechanism of Action | Cytochrome P450 1A Inducers |
Anatomical Therapeutic Chemical (ATC) Classes for ALBENZA
US Patents and Regulatory Information for ALBENZA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Labs Inc | ALBENZA | albendazole | TABLET;ORAL | 020666-001 | Jun 11, 1996 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
